Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Eurasian J Med ; 52(1): 67-72, 2020 Feb.
Article in English | MEDLINE | ID: mdl-32158318

ABSTRACT

OBJECTIVE: We aimed to investigate the relationship between the use of fluoro-2-deoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT), maximized standardized uptake value (SUVmax) values of tumors, and tumor differentiation and tumor markers during the initial staging of patients with gastric cancer. MATERIALS AND METHODS: The study included 50 patients (14 women and 36 men; mean age: 63±11 years; age range: 31-80 years) who had undergone initial staging with FDG-PET/CT after the diagnosis of gastric cancer with endoscopic biopsy between January and June 2013. Serum alpha fetoprotein (AFP), carcinogenic antigen 19-9 (CA 19.9), carcinoembryonic antigen (CEA), and C-reactive protein (CRP) levels were measured in patients prior to imaging. PET/CT images were evaluated for primary tumors, locoregional spread, and distant organ metastases, and classified by tumor-node-metastasis staging. Semiquantitative data were collected by SUVmax measurements in pathological regions of involvement. Data were analyzed statistically. RESULTS: FDG-PET/CT showed primary gastric cancer with a sensitivity of 87%. Imaging findings were normal in 3 patients (1/3; mucinous adenocarcinoma, 2/3; signet-ring cell adenocarcinoma). With FDG-PET/CT, 3/50 patients were classified into Stage 1B, 3/50 patients into Stage 2, 5/50 patients into Stage 3A, 5/50 patients into Stage 3B, 5/50 patients into 3C and 29/50 patients into Stage 4. The mean SUVmax was calculated as 11.35±4.3 (poorly differentiated adenocarcinoma: 5.4±1.7; moderately differentiated adenocarcinoma: 10.3±4.8) for the primary tumor and 14.9±6.3 for tumor metastasis. A positive correlation was evident between the measured SUVmax and stage and the grade of primary tumor (p<0.05). While the relationship between SUVmax and levels of serum AFP and CRP was statistically significant (p<0.05), the relationship between SUVmax and levels of serum CA 19-9 and CEA was not statistically significant (p>0.05). CONCLUSION: The SUVmax of primary tumors was associated with the degree of differentiation of primary tumors and the biochemical tumor markers CRP and AFP. The fact that SUVmax of primary tumors is high supplies clues about the presence of the factors affecting prognosis of the disease.

2.
Mater Sci Eng C Mater Biol Appl ; 75: 663-670, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28415513

ABSTRACT

Curcumin-loaded solid lipid nanoparticles (C-SLNs) were prepared using micro emulsion and ultrasonication methods in the first stage of this study to determine the role of C-SLN on liver-spleen scintigraphy. It was concluded that the curcumin that was encapsulated in solid lipid nanoparticles had a ß' polymorph structure according to the X-ray diffraction (XRD) analysis. It was concluded that these particles were at nano scale according to the laser diffraction (LD) analysis. Fourier transform infrared spectroscopy (FT-IR) analysis suggested an interaction between the curcumin and the solid lipid matrix, and the curcumin was loaded on the solid lipid nanoparticles. Moreover, the particles were concluded to be spherical and at nanoscale according to the scanning electron microscopy (SEM) and transmission electron microscopy (TEM) images. On the other hand, thermogravimetric analysis (TGA) suggested that the curcumin loaded solid nanoparticles were stable against the temperature. C-SLNs were labeled with Technetium-99m (99mTc) radioisotope in the second stage of the study, then using scintigraphic methods in-vivo studies were performed on New Zealand rabbit and made a comparison with Phytate colloid, routinely used in liver-spleen scintigraphy. After analyzing the images and the biological distributions obtained from the experiments, uptake was observed in the liver and the spleen. Following from the experiment results, 99mTc-labeled C-SLNs was concluded to be a possible imaging agent. In particular, it could be a new radiopharmaceutical alternative to 99mTc-labeled compounds that are used in liver and spleen imaging in colloid scintigraphy.


Subject(s)
Curcumin , Liver/diagnostic imaging , Nanoparticles/chemistry , Radiopharmaceuticals , Spleen/diagnostic imaging , Technetium , Animals , Curcumin/chemistry , Curcumin/pharmacology , Isotope Labeling/methods , Male , Rabbits , Radionuclide Imaging/methods , Radiopharmaceuticals/chemistry , Radiopharmaceuticals/pharmacology , Technetium/chemistry , Technetium/pharmacology
3.
Acta Radiol ; 58(8): 1005-1011, 2017 Aug.
Article in English | MEDLINE | ID: mdl-27864568

ABSTRACT

Background Different non-invasive imaging techniques such as Doppler ultrasonography and renal scintigraphy are commonly employed to assess allograft function and associated complications. However, all such methods lack sufficient specificity to discriminate between residual renal function of native kidneys. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluates signal dynamics during the passage of contrast material through the renal cortex, medulla, and collecting system. Purpose To investigate the value of DCE 3T MRI using a quantitative pharmacokinetic parameter (Ktrans) for the assessment of native kidneys before and after pre-emptive renal transplantation. Material and Methods Twenty-five consecutive patients with end-stage renal disease underwent DCE MRI before and 6 months after kidney transplantation. MRI was performed using a 3T scanner. Regions of interests were drawn over each kidney, encompassing the cortex and medulla but excluding the collecting system and any coexisting cysts. Parametric Ktrans values were automatically generated. Results In the pre-transplantation group, mean Ktrans values for the right and left kidneys were 0.55 ± 0.09 min-1 and 0.44 ± 0.15 min-1, respectively. In the post-transplantation group, mean Ktrans values of the right and left kidneys were 0.27 ± 0.07 min-1 and 0.25 ± 0.10 min-1, respectively. There were statistically significant differences between right and left kidneys in terms of mean Ktrans values in the pre- and post-transplantation groups ( P < 0.001). Conclusion Our preliminary results show that native kidneys were still functioning 6 months after transplantation. MR perfusion using Ktrans may constitute a non-invasive means of determination of the viability of native kidneys after renal transplantation.


Subject(s)
Contrast Media/pharmacokinetics , Gadolinium DTPA/pharmacokinetics , Kidney Transplantation , Kidney/diagnostic imaging , Magnetic Resonance Imaging/methods , Adult , Female , Glomerular Filtration Rate , Humans , Male , Sensitivity and Specificity
4.
Turk J Med Sci ; 46(4): 1025-32, 2016 Jun 23.
Article in English | MEDLINE | ID: mdl-27513400

ABSTRACT

BACKGROUND/AIM: Accurate measurement of glomerular filtration rate (GFR) in the evaluation of renal functions in potential kidney donors is associated with important outcomes for both the donor and recipient. We intended to determine the efficacy of various methods while estimating GFR in potential living kidney donors. MATERIALS AND METHODS: Fifty-three potential kidney donors (31 females, 22 males; mean age: 50.1 years) were included in this study. GFR was estimated simultaneously using the following methods: Gates' method, Cockcroft-Gault (CG) and modification of diet in renal disease (MDRD) prediction equations, and the two-plasma sample (TPS) technique. Using TPS as the reference method, the estimations of GFR with the other methods were compared with that of TPS. RESULTS: The mean ± SD GFR was 86.43 ± 11.37 mL min-1 1.73 m-2 with TPS. GFR values calculated using Gates' method and MDRD 1, MDRD 2, reexpressed MDRD, and CG prediction equations were 105.25 ± 16.12 mL min-1 1.73 m-2, 114.63 ± 32.51 mL min-1 1.73 m-2, 113.2 ± 35.23 mL min-1 1.73 m-2, 104.23 ± 23.12 mL min-1 1.73 m-2, and 99.35 ± 20.01 mL min-1 1.73 m-2, respectively. While there was a strong statistically significant correlation between the TPS and Gates' methods, moderate correlation was found between TPS and the MDRD 1, MDRD 2, and reexpressed MDRD prediction equations. CONCLUSION: Our results indicated that the performance of Gates' method in total GFR estimation was better than the prediction equations in potential kidney donors.


Subject(s)
Glomerular Filtration Rate , Creatinine , Female , Humans , Kidney Transplantation , Living Donors , Male , Middle Aged , Technetium Tc 99m Pentetate
5.
J Enzyme Inhib Med Chem ; 31(sup1): 141-147, 2016.
Article in English | MEDLINE | ID: mdl-27143114

ABSTRACT

The inhibitory effects of methoxyisobutylisonitrile (MIBI), diethylene triamine pentaacetic acid (DTPA), dimercaptosuccinic acid (DMSA) and metilendifosfonat (MDP) on human erythrocyte glucose 6-phosphate dehydrogenase (hG6PD) activity were investigated. For this purpose, hG6PD was initially purified 557-fold at a yield of 51.43% using 2',5'-adenosine diphosphate (ADP) sepharose 4B affinity gel chromatography. The in vitro effects of these chelators on hG6PD enzyme were studied. IC50 values of MIBI, DTPA, DMSA and MDP were 0.056, 0.172, 0.274 and 0.175 mM, of hG6PD, respectively. It was detected in in vitro studies that the hG6PD enzyme is inhibited due to these radiopharmaceutical chelators. In addition to in vitro studies, in order to better understand the molecular mechanism of studied compounds, combined in silico approaches, including molecular docking and molecular dynamics (MD), simulations were successfully performed. MD simulations shed light on inhibition mechanisms of the individual inhibitors into the ligand-binding pocket of hG6PD. Essential amino acids for binding are also investigated using per-residue interaction analysis studies.


Subject(s)
Chelating Agents/chemistry , Chelating Agents/pharmacology , Computer Simulation , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Glucosephosphate Dehydrogenase/antagonists & inhibitors , Organotechnetium Compounds/chemistry , Chelating Agents/chemical synthesis , Chromatography, Affinity , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Glucosephosphate Dehydrogenase/isolation & purification , Glucosephosphate Dehydrogenase/metabolism , Humans , In Vitro Techniques , Molecular Structure , Organotechnetium Compounds/isolation & purification , Structure-Activity Relationship
6.
Inflammation ; 39(1): 336-346, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26412256

ABSTRACT

This study was performed to evaluate the possible protective effect of two calcium channel blocker's "lacidipine (LAC) and amlodipine (AML)" on bone metabolism in an experimental ovariectomized and inflammation-induced osteoporosis rat model (OVXinf). For the purpose of this study, the rats were divided into eight groups, each containing eight rats: sham-operated control (group 1, SH), sham + inflammation (group 2, SHinf), ovariectomy (group 3, OVX), ovariectomy + inflammation (group 4, OVXinf), ovariectomy + LAC 4 mg/kg (group 5, OVX + LAC), ovariectomy + inflammation + LAC 4 mg/kg (group 6, OVXinf + LAC), ovariectomy + AML 5 mg/kg (group 7, OVX + AML), ovariectomy + inflammation + AML 5 mg/kg (group 8, OVXinf + AML). The levels of osteocalcin and osteopontin decreased in OVXinf + LAC and OVXinf + AML groups. The serum levels of TNF-α, IL-1ß, and IL-6 were increased significantly in the OVXinf rats compared with the SH group. Gene expression levels of the osteogenic factor runt-related transcription factor 2 (Runx2) and type I collagen 1A1 (Col1A1) significantly decreased in the OVXinf group, when compared with the control group. AML or LAC administrations increased the levels of Runx2 and Col1A1. These results suggest that amlodipine and lacidipine may be a novel therapeutic target for radical osteoporosis treatment in hypertensive patients.


Subject(s)
Amlodipine/pharmacology , Bone Density/drug effects , Calcium Channel Blockers/pharmacology , Dihydropyridines/pharmacology , Osteoporosis/prevention & control , Ovariectomy , Animals , Collagen Type I/biosynthesis , Collagen Type I, alpha 1 Chain , Core Binding Factor Alpha 1 Subunit/biosynthesis , Female , Humans , Hypertension/drug therapy , Inflammation/pathology , Interleukin-1beta/blood , Interleukin-6/blood , Osteocalcin/metabolism , Osteopontin/metabolism , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/blood
7.
Turk J Med Sci ; 45(3): 674-7, 2015.
Article in English | MEDLINE | ID: mdl-26281338

ABSTRACT

BACKGROUND/AIM: Isotretinoin is an effective drug utilized in the management of acne vulgaris and is known to cause dry mouth. In this study, we aimed to evaluate this effect of isotretinoin on the salivary gland function in patients with acne vulgaris using technetium-99m (Tc-99m) pertechnetate imaging of the salivary glands. MATERIALS AND METHODS: The study population consisted of 28 patients with acne vulgaris (6 males and 22 females, mean age 20.2 ± 2.3 years), who were treated with isotretinoin for 6 months. We performed radionuclide imaging of the salivary glands pretreatment and at months 3 and 6 of treatment. After 185 MBq (5 mCi) of Tc-99m pertechnetate was intravenously administered, imaging of the salivary glands was performed over a 25-min period. We measured the following glandular function parameters for the parotid and submandibular salivary glands via time-activity curves: uptake ratio, maximum accumulation, and ejection fraction. RESULTS: Statistically significant differences were observed in the values obtained at months 3 and 6 of treatment, compared with the pretreatment values. CONCLUSION: This study demonstrated that radionuclide imaging of the salivary glands can clearly show the glandular functions that are affected by drugs such as isotretinoin.


Subject(s)
Acne Vulgaris/drug therapy , Dermatologic Agents/pharmacology , Isotretinoin/pharmacology , Radiopharmaceuticals , Salivary Glands/diagnostic imaging , Sodium Pertechnetate Tc 99m , Adolescent , Adult , Female , Follow-Up Studies , Humans , Male , Radionuclide Imaging , Salivary Glands/drug effects , Young Adult
8.
Basic Clin Pharmacol Toxicol ; 117(3): 173-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25625309

ABSTRACT

The aim of this study was to examine the effects of carnitine on bone healing in ovariectomy (OVX) and inflammation (INF)-induced osteoporotic rats. The rats were randomly divided into nine groups (n = 8 animals per group): sham-operated (Group 1: SHAM); sham + magnesium silicate (Mg-silicate) (Group 2: SHAM + INF); ovariectomy (Group 3: OVX); ovariectomy + femoral fracture (Group 4: OVX + FRC); ovariectomy + femoral fracture + Mg-silicate (Group 5: OVX + FRC + INF); ovariectomy + femoral fracture + carnitine 50 mg/kg (Group 6: OVX + FRC + CAR50); ovariectomy + femoral fracture + carnitine 100 mg/kg (Group 7: OVX + FRC + CAR100); ovariectomy + femoral fracture + Mg-silicate + carnitine 50 mg/kg (Group 8: OVX + FRC + INF + CAR50); and ovariectomy + femoral fracture + Mg-silicate + carnitine 100 mg/kg (Group 9: OVX + FRC + INF + CAR100). Eight weeks after OVX, which allowed for osteoporosis to develop, INF was induced with subcutaneous Mg-silicate. On day 80, all of the rats in groups 4-9 underwent fracture operation on the right femur. Bone mineral density (BMD) showed statistically significant improvements in the treatment groups. The serum markers of bone turnover (osteocalcin and osteopontin) and pro-inflammatory cytokines (tumour necrosis factor α, interleukin 1ß and interleukin 6) were decreased in the treatment group. The X-ray images showed significantly increased callus formation and fracture healing in the groups treated with carnitine. The present results show that in a rat model with osteoporosis induced by ovariectomy and Mg-silicate, treatment with carnitine improves the healing of femur fractures.


Subject(s)
Carnitine/therapeutic use , Fracture Healing/drug effects , Inflammation/complications , Osteoporosis/complications , Absorptiometry, Photon , Animals , Bone Density , Disease Models, Animal , Female , Interleukin-1beta/blood , Interleukin-6/blood , Osteocalcin/blood , Osteopontin/blood , Ovariectomy , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/blood
9.
Hell J Nucl Med ; 17(3): 190-3, 2014.
Article in English | MEDLINE | ID: mdl-25397624

ABSTRACT

The aim of this study was to evaluate the possible favorable effect of desloratadine-montelukast combination on salivary glands (SG) function in patients with allergic rhinitis (AR) using SG scintigraphy. The study population consisted of 64 patients with AR and 28 healthy controls: 14 males and 14 females, with mean age 32.3±8.6 years. The patients were divided into two groups: the untreated patients group of 32 patients, 16 males and 16 females, mean age 28.5±5.4 years and the treated group, who received the standard clinically recommended oral dose of montelukast 10mg/d and desloratadine 5mg/d for 6 weeks. This group consisted of 32 patients, 16 males and 16 females, mean age 38.3±8.4 years. All patients and healthy controls underwent SG scintigraphy. After the intravenous injection of technetium-99m pertechnetate, ((99m)Tc-P), dynamic SG scintigraphy was performed for 25min. Using the time-activity curves, the following glandular function parameters were calculated for the parotid and the submandibular SG: uptake ratio, maximum accumulation and ejection fraction. Results showed SG hypofunction. All functional parameters obtained for the untreated patients and for the desloratadine-montelukast treated patients were significantly lower than those in healthy controls (P<0.05). There was no statistically significant difference between treated and untreated patients (P>0.05). In conclusion, our study showed that hypofunction of SG was present in all patients with AR. This hypofunction, as tested by semi-quantitative SG scintigraphy, and also the quality of life did not improve after treatment with montelukast and desloratadine.


Subject(s)
Acetates/administration & dosage , Acetates/adverse effects , Loratadine/analogs & derivatives , Quinolines/administration & dosage , Quinolines/adverse effects , Rhinitis, Allergic/diagnostic imaging , Rhinitis, Allergic/drug therapy , Xerostomia/chemically induced , Xerostomia/diagnostic imaging , Adult , Anti-Allergic Agents/administration & dosage , Anti-Allergic Agents/adverse effects , Cyclopropanes , Drug Therapy, Combination/adverse effects , Drug Therapy, Combination/methods , Female , Histamine H1 Antagonists, Non-Sedating/administration & dosage , Histamine H1 Antagonists, Non-Sedating/adverse effects , Humans , Loratadine/administration & dosage , Loratadine/adverse effects , Male , Radionuclide Imaging , Rhinitis, Allergic/complications , Salivary Glands/diagnostic imaging , Salivary Glands/drug effects , Sulfides , Treatment Outcome
10.
Mater Sci Eng C Mater Biol Appl ; 44: 246-53, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25280703

ABSTRACT

Scaffold-based bone defect reconstructions still face many challenges due to their inadequate osteoinductive and osteoconductive properties. Various biocompatible and biodegradable scaffolds, combined with proper cell type and biochemical signal molecules, have attracted significant interest in hard tissue engineering approaches. In the present study, we have evaluated the effects of boron incorporation into poly-(lactide-co-glycolide-acid) (PLGA) scaffolds, with or without rat adipose-derived stem cells (rADSCs), on bone healing in vitro and in vivo. The results revealed that boron containing scaffolds increased in vitro proliferation, attachment and calcium mineralization of rADSCs. In addition, boron containing scaffold application resulted in increased bone regeneration by enhancing osteocalcin, VEGF and collagen type I protein levels in a femur defect model. Bone mineralization density (BMD) and computed tomography (CT) analysis proved that boron incorporated scaffold administration increased the healing rate of bone defects. Transplanting stem cells into boron containing scaffolds was found to further improve bone-related outcomes compared to control groups. Additional studies are highly warranted for the investigation of the mechanical properties of these scaffolds in order to address their potential use in clinics. The study proposes that boron serves as a promising innovative approach in manufacturing scaffold systems for functional bone tissue engineering.


Subject(s)
Boron/chemistry , Lactic Acid/chemistry , Polyglycolic Acid/chemistry , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Absorptiometry, Photon , Animals , Biocompatible Materials/chemistry , Bone Regeneration , Bone and Bones/drug effects , Bone and Bones/metabolism , Boron/pharmacology , Calcification, Physiologic , Cell Survival/drug effects , Collagen Type I/metabolism , Immunohistochemistry , Lactic Acid/pharmacology , Microscopy, Electron, Scanning , Osteocalcin/metabolism , Polyglycolic Acid/pharmacology , Polylactic Acid-Polyglycolic Acid Copolymer , Rats , Rats, Sprague-Dawley
11.
Mol Imaging Radionucl Ther ; 23(2): 74-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24963451

ABSTRACT

The present study gives a detailed report of a patient with atypical Cogan's syndrome with uveitis and sensorineural hearing loss. Cogan's syndrome is characterized by nonsyphilitic interstitial keratitis and audiovestibular dysfunction. This syndrome can be divided into two groups, typical and atypical, based on the presence of interstitial keratitis. It may sometimes be associated with systemic vasculitis. Fluoro-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) scanning was used to investigate the presence of vasculitis. With FDG-PET/CT scanning, there is no pathological involvement in the walls of the arteries; thus the patient is protected from aggressive and long term immunosuppressive treatment's side effects. Hence, we can conclude that FDG-PET/CT may play an important role in excluding the presence of vasculitis.

12.
Jpn J Radiol ; 31(12): 823-5, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24178153

ABSTRACT

Vesicoureteral reflux (VUR) is a well-recognized condition in the pediatric population, but is less well described in the adult population, and its prevalence decreases with increasing age. We describe the case of a 53-year-old male with nonfunctional kidney in which accumulation of radioactivity was observed in the ureter and renal pelvis owing to VUR, which was detected by technetium-99m diethylenetriamine pentaacetic acid dynamic renal scintigraphy.


Subject(s)
Kidney Failure, Chronic/complications , Vesico-Ureteral Reflux/diagnostic imaging , Humans , Kidney Pelvis/diagnostic imaging , Male , Middle Aged , Radionuclide Imaging , Technetium Tc 99m Pentetate , Ureter/diagnostic imaging , Vesico-Ureteral Reflux/complications
13.
Indian J Nucl Med ; 28(3): 171-2, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24250027

ABSTRACT

We report a case of a patient with hepatocellular carcinoma (HCC) who presented with back pain related to bone metastasis. HCC metastasizes by hematogenous and lymphatic routes commonly to the lungs, regional lymph nodes, kidney, bone marrow and adrenals. In this extremely rare case, the patient had no known liver disease, but presented with liver lesions and multiple bone lesions involving vertebrae, ribs, pelvic bones and left femur with associated expansile soft-tissue components. These bone lesions were first detected from a positron emission tomography scan. Pathological examination of biopsy material taken from the left eighth rib confirmed metastatic HCC. In conclusion, if a patient has expansile osteolytic bone lesions, bone metastasis from HCC should be included in the differential diagnosis.

14.
Exp Biol Med (Maywood) ; 238(12): 1406-12, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24131539

ABSTRACT

This study was carried out to assess the protective bone-sparing effect of carnitine with anti-inflammatory properties on chronic inflammation-induced bone loss in ovariectomised (OVX) rats. A total of 64 rats were divided into eight groups. Sixteen rats were sham-operated (SH) while the others were ovariectomised (OVX). (1) SH, (2) sham + inflammation (SHinf), (3) OVX, (4) ovariectomy + inflammation (OVXinf), (5) OVX + CAR1, (6) OVX + CAR2, (7) OVXinf + CAR1, (8) OVXinf + CAR2. After the ovariectomy surgery, all the groups (3, 4, 5, 6, 7, and 8) were allowed to recover for two months. Sixty days after the OVX, inflammation was induced by subcutaneous injections of talc in groups 2, 4, 7, and 8. Group 5 and 7 were given 50 mg/kg CAR; Group 6 and 8 were given 100 mg/kg CAR from the 60th to the 80th day. Serum levels of TNF-α, IL-1, IL-6, OP, and OC were assessed to determine inflammation and to evaluate osteoblastic activity. Bone mineral density (BMD) was assessed by dual energy X-ray absorptiometry in femur bones of rats. Carnitine administration was able to restore BMD up to values measured in both the OVX and the SH animals. The serum levels of TNF-α, IL-1ß, and IL-6 were increased significantly in the OVXinf rats compared with the SH group. In OVX rats, inflammation which is evaluated by serum cytokine levels exacerbated this bone loss, as supported by values of BMD of the total femur. The two different doses of carnitine reduced bone loss and improved inflammatory biomarkers.


Subject(s)
Carnitine/pharmacology , Inflammation/complications , Osteoporosis/etiology , Ovariectomy , Absorptiometry, Photon , Animals , Bone Density/drug effects , Female , Inflammation/chemically induced , Interleukin-1/blood , Interleukin-6/blood , Magnesium Silicates/pharmacology , Osteocalcin/blood , Osteopontin/blood , Osteoporosis/prevention & control , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/blood
15.
Adv Ther ; 30(9): 834-44, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24057341

ABSTRACT

INTRODUCTION: Percutaneous coronary intervention (PCI) does not often produce optimal results, despite restoration of coronary blood flow at myocardial recovery, because of impaired microvascular perfusion. This study aimed to investigate and evaluate with (99m)Tc-sestamibi scan whether the results of PCI can be changed by maintenance infusion of tirofiban for 24 or 48 h in patients presenting with anterior ST-elevation myocardial infarction (STEMI). METHODS: The study included 84 patients with anterior STEMI who were candidates for primary PCI and whose occlusion was in the proximal or mid-left anterior descending artery. Patients were given 25 µg/kg/3 min tirofiban and randomized to receive maintenance infusion at 0.15 µg/kg/min for 24 or 48 h. A resting (99m)Tc sestamibi scan was performed on the 5th day post-procedure before discharge. The primary efficacy endpoint was a patient's score on a 5-point scoring system for perfusion defect severity. Major adverse cardiac events (MACE) were defined as death from any cause, re-infarction, and clinically driven target-vessel revascularization within the first 6 months. RESULTS: Baseline characteristics of the patients were similar in the two infusion groups (n = 42 per group). There was no significant difference in the symptom onset-to-presentation time or door-to-balloon time between the two groups. With the exception of basal anteroseptal and basal anterior segments, significant reductions were obtained on the 5-point scoring system for perfusion defect severity in segments and in the summed rest scores. No significant differences were observed between the two groups in the incidence of MACE at 6 months. The safety profile did not differ between 24 and 48 h infusions of tirofiban. CONCLUSION: The use of tirofiban, when administered at a high bolus dose and maintained for 48 h, was safe and significantly reduced perfusion defect severity in patients with anterior STEMI presenting early after symptom onset and undergoing primary PCI.


Subject(s)
Angioplasty, Balloon, Coronary/methods , Anterior Wall Myocardial Infarction/therapy , Heart/diagnostic imaging , Platelet Aggregation Inhibitors/therapeutic use , Tyrosine/analogs & derivatives , Aged , Combined Modality Therapy , Coronary Angiography , Female , Humans , Male , Middle Aged , Myocardial Perfusion Imaging , Myocardial Reperfusion , Radiopharmaceuticals , Single-Blind Method , Technetium Tc 99m Sestamibi , Tirofiban , Treatment Outcome , Tyrosine/therapeutic use
16.
Hell J Nucl Med ; 16(2): 107-10, 2013.
Article in English | MEDLINE | ID: mdl-23865083

ABSTRACT

Chronic renal failure and its treatment can induce oral health problems and salivary glands dysfunction. The purpose of this study was to assess salivary glands function in patients with kidney transplantation using technetium-99m pertechnetate ((99m)Tc-P) salivary glands scintigraphy. We prospectively studied 34 patients with kidney transplantation (30 males and 4 females,mean age 39.76±11.6 years) and 28 healthy controls (12 males and 16 females, mean age 36.1±9.5 years). Salivary gland scintigraphy was performed nearly 4.4±2.9 years after successful kidney transplantation. Dynamic salivary glands scintigraphy was performed during 25min after the intravenous administration of 185MBq of (99m)Tc-P. Time-activity curves and glands functional parameters were calculated for the parotid and submandibular salivary glands: uptake ratio, maximum accumulation of the radionuclide, and excretion fraction. Statistical analysis of the functional parameters showed no significant differences between patients with kidney transplantation and healthy controls (P>0.05). In conclusion, this study showed that using (99m)Tc-P salivary gland scintigraphy, salivary glands function of patients with successful kidney transplantation do not differ statistically from those in healthy controls.


Subject(s)
Kidney Failure, Chronic/diagnostic imaging , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Kidney Transplantation/diagnostic imaging , Salivary Gland Diseases/diagnostic imaging , Salivary Gland Diseases/etiology , Sodium Pertechnetate Tc 99m , Adult , Female , Humans , Kidney Failure, Chronic/complications , Male , Radionuclide Imaging , Radiopharmaceuticals , Reproducibility of Results , Salivary Glands/diagnostic imaging , Sensitivity and Specificity , Treatment Outcome
17.
Hell J Nucl Med ; 13(1): 26-9, 2010.
Article in English | MEDLINE | ID: mdl-20411167

ABSTRACT

The purpose of this study was to evaluate the alterations in salivary gland function in patients who receiving continuous ambulatory peritoneal dialysis (CAPD) for chronic renal failure (CRF) using technetium-99m pertechnetate ((99m)Tc-P) salivary gland scintigraphy. The study population consisted of 36 CAPD patients (16 males and 20 females, ranging in age from 19 to 73 years, mean age 44.94+/-15.01 years) and 20 healthy controls (11 males and 9 females, ranging in age from 31 to 51 years, mean age 41.25+/-5.62 years). All patients and healthy controls underwent salivary gland scintigraphy. After the intravenous administration of 185MBq of (99m)Tc-P, dynamic salivary gland scintigraphy was performed for 25min. On the basis of the time-activity curves, the following glandular function parameters were calculated for the parotid and submandibular salivary glands: uptake ratio, maximum accumulation, and ejection fraction. Our results showed: All functional parameters obtained for CAPD patients were significantly lower than for healthy controls (P<0.05). In conclusion, this study demonstrated that salivary gland function, an important determinant of oral health, is impaired among the CRF patients treated with CAPD compared with healthy controls, as evaluated by (99m)Tc-P salivary gland scintigraphy.


Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Salivary Glands/diagnostic imaging , Sodium Pertechnetate Tc 99m , Xerostomia/diagnostic imaging , Xerostomia/etiology , Adult , Aged , Female , Humans , Male , Middle Aged , Radionuclide Imaging , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity , Young Adult
18.
Hell J Nucl Med ; 12(2): 119-22, 2009.
Article in English | MEDLINE | ID: mdl-19675863

ABSTRACT

The purpose of this study was to assess the effect of levocetirizine (xyzal) on salivary glands function in patients with allergic rhinitis using technetium-99m pertechnetate ((99m)Tc-P) salivary gland scintigraphy. The study population consisted of 67 patients with allergic rhinitis and 31 healthy controls (14 males and 17 females, mean age 30.1+/-6.8 years). The patients were divided into two groups: an untreated patient Group of 32 patients, 17 males and 15 females, mean age 29.9+/-6.5 years and a levocetirizine-treated with 5mg.day(-1) for 4 weeks patient Group, consisted of 35 patients, 16 males and 19 females, mean age 33.5+/-7.8 years. All patients and healthy controls underwent salivary glands scintigraphy. After the intravenous administration of 185 MBq of (99m)Tc-P, dynamic salivary glands scintigraphy was performed for 25 min. By the time-activity curves, the following glandular function parameters were calculated for the parotid and submandibular salivary glands: uptake ratio, maximum accumulation, and ejection fraction. Our results showed: All functional parameters obtained for the untreated patient Group were significantly lower than for the levocetirizine-treated patient Group and healthy controls (P<0.05). There was no significant difference in any functional parameters between the levocetirizine-treated patient Group and healthy controls (P>0.05). In conclusion, results of our study indicate that patients with allergic rhinitis treated with levocetirizine showed a significantly higher salivary glands function compared with untreated patients and healthy controls. Levocetirizine treatment showed no side effects on salivary glands function.


Subject(s)
Cetirizine/administration & dosage , Cetirizine/adverse effects , Rhinitis, Allergic, Seasonal/diagnostic imaging , Rhinitis, Allergic, Seasonal/drug therapy , Sodium Pertechnetate Tc 99m , Xerostomia/chemically induced , Xerostomia/diagnostic imaging , Adult , Female , Histamine H1 Antagonists, Non-Sedating/administration & dosage , Histamine H1 Antagonists, Non-Sedating/adverse effects , Humans , Male , Middle Aged , Radionuclide Imaging , Radiopharmaceuticals , Rhinitis, Allergic, Seasonal/complications , Salivary Glands/drug effects , Treatment Outcome , Young Adult
19.
Nucl Med Biol ; 36(5): 575-8, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19520299

ABSTRACT

INTRODUCTION: Nuclear medicine workers are occupationally exposed to chronic ionizing radiation. It is known that ionizing radiation may have damaging effects on chromosomes. In the present study, we investigated the genotoxic effects of ionizing radiation on nuclear medicine workers. We used two different indicators of genotoxicity methods: sister chromatid exchange (SCE) and micronucleus (MN). METHODS: The present research was carried out using 21 nuclear medicine workers (11 females and 10 males) during two periods: during normal working conditions and after a 1-month vacation. The radiation dose varied from 1.20 to 48.56 mSv, which accumulated during the occupational exposure time between two vacations. Peripheral blood samples were taken from each subject for two distinct lymphocyte cultures (SCE and MN) in each period. RESULTS: In nearly all subjects, SCE values increased significantly during radiation exposure compared to the postvacation period (P<.05). Similarly, MN frequencies in most of the subjects increased significantly during radiation exposure compared to the postvacation period (P<.05). CONCLUSIONS: This study revealed that both SCE and MN frequencies in most of the subjects were significantly higher during exposure to ionizing radiation than after a 1-month vacation period. However, this genotoxic effect was reversible in most of the subjects.


Subject(s)
Nuclear Medicine , Occupational Exposure/adverse effects , Radiation Dosage , Adult , Animals , Holidays , Humans , Lymphocytes/radiation effects , Male , Micronucleus Tests , Mutagenicity Tests , Sister Chromatid Exchange/radiation effects , Time Factors , Workforce
SELECTION OF CITATIONS
SEARCH DETAIL
...